Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jose E. Batista"'
Autor:
Jose E. Batista Miranda, Guillherm Ramos, Juan Francisco Monzon Falconi, Anais Bassas Parga, Damian Cuny
Publikováno v:
Continence, Vol 11, Iss , Pp 101133- (2023)
Externí odkaz:
https://doaj.org/article/fba5140abc1248c197f38d7ff4582113
Autor:
Jose E. Batista, Heinz Kölbl, Sender Herschorn, Tomasz Rechberger, Javier Cambronero, Michael Halaska, Alex Coppell, Mathilde Kaper, Moses Huang, Emad Siddiqui
Publikováno v:
Therapeutic Advances in Urology, Vol 7 (2015)
Objective: To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy. Patients and methods: This randomized, double-bli
Externí odkaz:
https://doaj.org/article/408c607d50924e1ca9f74329f99aebe2
Autor:
Heinz Kölbl, Tomasz Rechberger, Javier Cambronero, Moses Huang, Alex Coppell, Jose E. Batista, Sender Herschorn, Mathilde Kaper, Michael J. Halaska, Emad Siddiqui
Publikováno v:
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Therapeutic Advances in Urology, Vol 7 (2015)
Consejería de Sanidad de la Comunidad de Madrid
Therapeutic Advances in Urology, Vol 7 (2015)
Objective: To compare the efficacy and safety of mirabegron 50 mg and solifenacin 5 mg in overactive bladder (OAB) patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy. Patients and methods: This randomized, double-bli
Autor:
Andrea Tubaro, Victor W. Nitti, Jose E. Batista, Emad Siddiqui, Christopher R. Chapple, Mary Beth Blauwet, Sender Herschorn, Moses Huang, Matthias Oelke
Publikováno v:
Therapeutic Advances in Urology, 9(6), 137-154. SAGE Publications Ltd
Therapeutic Advances in Urology, Vol 9 (2017)
Therapeutic Advances in Urology, Vol 9 (2017)
Background: Oral pharmacotherapies to treat overactive bladder (OAB) are used less in men despite a similar prevalence of storage symptoms as women. The efficacy and safety of once-daily mirabegron 50 mg was evaluated in male OAB patients from five p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5cfceae6e69ff912993cd007ab68c7
https://cris.maastrichtuniversity.nl/en/publications/6724c086-ae27-447e-984e-40448b031d40
https://cris.maastrichtuniversity.nl/en/publications/6724c086-ae27-447e-984e-40448b031d40
Publikováno v:
Urology. 69:285-288
OBJECTIVES To assess the impact of lower urinary tract symptoms (LUTS) on general quality-of-life (QOL) measures in an outpatient setting. METHODS A total of 1546 male patients aged 51 years or older and scoring more than 11 in the International Pros
Autor:
Emmanuel Chartier-Kastler, Andrea Tubaro, Herman Stoevelaar, Christopher R. Chapple, Richard Berges, Philip Van Kerrebroeck, Jose E. Batista
Publikováno v:
European Urology Supplements. 5:12-18
Although nocturia has been recognised as one of the most bothersome symptoms in men suffering from lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH), its impact on quality of life (QoL) is often underestimated. Recent
Autor:
Andrea Tubaro, Emmanuel Chartier-Kastler, Richard Berges, K Dreikorn, F Desgrandchamps, L Smets, M Perez, Franklin C. Lowe, J Trachtenberg, Giario Conti, Michael P. O'Leary, Herman Stoevelaar, M. Speakman, B Meesen, Jose E. Batista
Publikováno v:
Prostate Cancer and Prostatic Diseases, 8(4), 369-374. Nature Publishing Group
The RAND appropriateness method was used to explore the relevance of risk factors for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). A total of, 12 international exp
Publikováno v:
Urologia Internationalis. 74:341-345
Objectives: To evaluate the usefulness of bladder cycling (BC) in differentiating between urodynamic abnormalities due to reversible bladder dysfunction and those due to preexisting lower urinary tract (LUT) abnormalities, and to determine if BC incr
Publikováno v:
Neurourology and urodynamics. 31(5)
Aims: To highlight two main psychological factors (cognitive barriers and safety-behaviors) involved in the development and maintenance of emotional distress in patients with urinary incontinence (UI) and thus facilitate a better understanding of thi
Autor:
Richard Berges, Emmanuel Chartier-Kastler, Andrea Tubaro, Philip Van Kerrebroeck, Christopher R. Chapple, Jose E. Batista, Herman Stoevelaar
Broad consensus exists among both practicing urologists and urological experts about the importance of a careful evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH). Commonly used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e48325192dcd83f0d6f069e8c7e4628
http://hdl.handle.net/11573/107014
http://hdl.handle.net/11573/107014